AACC Booth Presentation: Why Labs Request Clinical Information: Examining the Impact on Patient Care
Use of genetic testing is increasing across all areas of medicine. However, test-ordering errors can adversely impact patient care and increase costs to patients and hospitals. Test-results interpretation can be improved by understanding clinical context. This presentation will utilize case examples.
Originally presented July 30, 2013 in Houston, Texas.
Elaine Lyon, PhD
Director, Genetics Division, ARUP Laboratories
Co-Medical Director, Pharmacogenomics, ARUP Laboratories
Co-Director, Clinical Molecular Genetics Fellowship Program, ARUP Laboratories
Associate Professor of Pathology, University of Utah School of Medicine
Dr. Lyon is the medical director of the Genetics Division, co-medical director of Pharmacogenomics, and co-director of the Molecular Genetics Fellowship Program at ARUP, and an associate professor of pathology at the University of Utah School of Medicine. She received her PhD in medical genetics from the University of Alabama at Birmingham and continued with fellowship training in clinical molecular genetics at the University of Utah. Dr. Lyon combines clinical laboratory responsibilities with research and development in human genetics, employing methods for mutation detection by targeted mutation analysis, gene sequencing, gene scanning, exonic-level deletion, and duplications and molecular haplotyping. Dr. Lyon has focused her interest in studies to determine the significance of rare variants and is involved with evaluating and establishing locus-specific databases that combine genetic variants with clinical symptoms.